Tornero Ruiz Jesús Ignacio, Martínez Gómez Gloria, Escudero Bregante José Félix, Gómez Gómez Guillermo Antonio
Servicio de Urología. Hospital Clínico Universitario Virgen de la Arrixaca. El Palmar. Murcia. España.
Arch Esp Urol. 2017 Mar;70(2):288-293.
The aim of our study is to demonstrate that intravesical administration of the association chondroitin sulfate (CS) and hyaluronic acid (HA), according to our treatment schedule, is a benefit for women with recurrent urinary tract infections (RUTI), not only from a clinical point of view, but also reducing recurrences.
This is a study of 28 women diagnosed with RUTI, with a positive culture, and compatible symptoms;frethey underwent treatment according to the protocol of intravesical instillations of the combination CS 2%-1 gr + HA 1.6%-800 mg. To evaluate the effectiveness of the treatment, symptoms improvement, reduction of the number of episodes of urinary tract infection and quality of life were considered.
In our series, we can observe an improvement of the quality of life assessed by PG-I, 66% after 12 months. It was seen that 55.6% of the patient's urine cultures became negative, while 44.4% had episodes of urinary infection, but with lower baseline symptoms intensity.
Patients included in the protocol of instillation improved significantly their quality of life; in addition, to a considerable extent new urinary infections were not presented, being milder when they presented.
我们研究的目的是证明,按照我们的治疗方案膀胱内给予硫酸软骨素(CS)和透明质酸(HA)联合制剂,对复发性尿路感染(RUTI)女性有益,不仅从临床角度来看如此,而且还能减少复发。
这是一项针对28名被诊断为RUTI、培养结果呈阳性且有相符症状的女性的研究;她们按照膀胱内灌注2%-1克CS + 1.6%-800毫克HA组合制剂的方案接受治疗。为评估治疗效果,考虑了症状改善情况、尿路感染发作次数的减少以及生活质量。
在我们的研究系列中,我们可以观察到,通过PG-I评估的生活质量在12个月后有66%得到改善。可以看到,55.6%患者的尿培养结果转为阴性,而44.4%有尿路感染发作,但基线症状强度较低。
纳入灌注方案的患者生活质量有显著改善;此外,相当程度上未出现新的尿路感染,即便出现也较为轻微。